{"product_id":"cancer-biomarkers","title":"Cancer Biomarkers","description":"\u003cp\u003eGleaning information from more than 100 experts in the field of cancer diagnosis, prognosis, and therapy worldwide, \u003cstrong\u003eCancer Biomarkers: Non-Invasive Early Diagnosis and Prognosis \u003c\/strong\u003edetermines the significance of clinical validation approaches for several markers. This book examines the use of noninvasive or minimally invasive molecular cancer markers that are under development or currently in use. It deals with a majority of commonly prevalent cancers and can help anyone working in the health-care industry to recommend or develop early diagnostics, at-risk tests, and prognostic biomarkers for various cancers. \u003c\/p\u003e\u003cp\u003eIt explores the practice of determining biomarkers by their characteristics and relative methodologies, and presents the most recent data as well as a number of current and upcoming early diagnostic noninvasive molecular markers for many common cancers. It also considers the sensitivity and specificity of markers, biomarker market, test providers, and patent information.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003e \u003cbr\u003e\u003cp\u003eApproximately 30-35 Cancer Specific Noninvasive Molecular Diagnostic Markers in a Single Volume\u003c\/p\u003e\u003c\/strong\u003e\u003c\/p\u003e\u003cp\u003eThe book details the general and technical aspects of noninvasive cancer markers. It covers imaging, cutting-edge molecular technologies for biomarker development, and noninvasive or minimally invasive sources of molecular markers, as well as quality control and ethical issues in cancer biomarker discovery. It also provides a detailed account of brain, head and neck, and oral cancer markers, and provides information on a number of gastrointestinal cancers, lung cancer, and mesothelioma markers. \u003c\/p\u003e\u003cp\u003e\u003cstrong\u003e \u003cbr\u003e\u003cp\u003eEmphasizes the Importance of Volatile Markers in Early Cancer Diagnosis\u003c\/p\u003e\u003c\/strong\u003e\u003c\/p\u003e\u003cul\u003e \u003cli\u003ePresents noninvasive early molecular markers in urological cancers\u003c\/li\u003e \u003cli\u003eDescribes gynecological and endocrine cancer markers \u003c\/li\u003e \u003cli\u003eDetails noninvasive markers of breast, ovarian, cervical, and thyroid cancers \u003c\/li\u003e \u003cli\u003eAddresses hematological malignancies \u003c\/li\u003e \u003cli\u003eContains information on noninvasive molecular markers in myelodysplastic syndromes, acute myeloid leukemia, Hodgkin’s lymphoma, and multiple myeloma\u003c\/li\u003e \u003cli\u003eProvides comprehensive information on diagnostic and prognostic biomarkers in cutaneous melanoma\u003c\/li\u003e \u003c\/ul\u003e\u003cp\u003eThis text considers molecular technologies for biomarker development, noninvasive or minimally invasive sources of molecular markers, and quality control and ethical issues in cancer biomarker discovery.\u003c\/p\u003e","brand":"Taylor \u0026 Francis","offers":[{"title":"Default Title","offer_id":45542179668206,"sku":"9781138076808","price":163.2,"currency_code":"AUD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0630\/9612\/7726\/files\/9781138076808.jpg?v=1720121211","url":"https:\/\/bookland.com.au\/products\/cancer-biomarkers","provider":"Book Land AU","version":"1.0","type":"link"}